Wegovy maker, Novo Nordisk, warns of price squeeze

诺和诺德(Wegovy的生产商)警告价格挤压

World Business Report

2026-02-05

8 分钟
PDF

单集简介 ...

The maker of Ozempic says tougher competition from generics in India and China will hit profits this year. Leanna Byrne speaks to its chief financial officer. Plus, Spain moves closer to banning social media for under-16s. And the United States renews a trade deal giving 32 African countries duty-free access to its market.
更多

单集文稿 ...

  • This BBC podcast is supported by ads outside the UK.

  • You can find your ideas more freely and in more shape.

  • Search for Lenovo's official website for Lenovo Creators.

  • A region where local trends have global reach.

  • Korean skincare has taken off with the craze of K-pop.

  • And future challenges are shared.

  • Look at climate risks.

  • Asia was the most exposed region to sea level rise in the world.

  • The Asia-specific podcast explores one big story shaping the region,

  • with essential insight from those who know it best.

  • Asia-specific from the BBC World Service.

  • Listen now.

  • Search for Asia-specific wherever you get your BBC podcasts.

  • Mozambique's maker is being weighed down by competition and pricing.

  • It's World Business Express from the BBC World Service.

  • I'm Liana Byrne.

  • One of the biggest threats to energy security is how easy it is to get critical minerals and Spain's another country that might ban social media for under 16s.

  • So, shares in the maker of Osempic,

  • Novo Nordisk dropped 17% today after it warned of a decline in sales this year.

  • The firm says its outlook was hit by fierce competition and the expiry of patents on the active ingredients in its way govy and osempic drugs in some markets.